These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 23440809

  • 1. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ, Solà I, Lathyris D, Karakitsiou DE, Simancas-Racines D.
    Cochrane Database Syst Rev; 2013 Jan 31; (1):CD006612. PubMed ID: 23440809
    [Abstract] [Full Text] [Related]

  • 2. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ, Solà I, Lathyris D.
    Cochrane Database Syst Rev; 2015 Jan 15; 1():CD006612. PubMed ID: 25590290
    [Abstract] [Full Text] [Related]

  • 3. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M.
    Cochrane Database Syst Rev; 2017 Aug 17; 8(8):CD006612. PubMed ID: 28816346
    [Abstract] [Full Text] [Related]

  • 4. Homocysteine lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ, Solà I, Lathyris D, Salanti G.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006612. PubMed ID: 19821378
    [Abstract] [Full Text] [Related]

  • 5. Interventions for lowering plasma homocysteine levels in dialysis patients.
    Nigwekar SU, Kang A, Zoungas S, Cass A, Gallagher MP, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli GF, Jardine MJ.
    Cochrane Database Syst Rev; 2016 May 31; 2016(5):CD004683. PubMed ID: 27243372
    [Abstract] [Full Text] [Related]

  • 6. Interventions for lowering plasma homocysteine levels in kidney transplant recipients.
    Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine MJ.
    Cochrane Database Syst Rev; 2015 May 04; 2015(5):CD007910. PubMed ID: 25938479
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic lidocaine for myocardial infarction.
    Martí-Carvajal AJ, Simancas-Racines D, Anand V, Bangdiwala S.
    Cochrane Database Syst Rev; 2015 Aug 21; 2015(8):CD008553. PubMed ID: 26295202
    [Abstract] [Full Text] [Related]

  • 8. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL, Algra A, van Gijn J.
    Cochrane Database Syst Rev; 2003 Aug 21; (1):CD001820. PubMed ID: 12535415
    [Abstract] [Full Text] [Related]

  • 9. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
    B-Vitamin Treatment Trialists' Collaboration.
    Am Heart J; 2006 Feb 21; 151(2):282-7. PubMed ID: 16442889
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy.
    Hidalgo R, Martí-Carvajal AJ, Kwong JS, Simancas-Racines D, Nicola S.
    Cochrane Database Syst Rev; 2012 Nov 14; 11():CD009077. PubMed ID: 23152267
    [Abstract] [Full Text] [Related]

  • 11. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
    Brunström M, Carlberg B.
    JAMA Intern Med; 2018 Jan 01; 178(1):28-36. PubMed ID: 29131895
    [Abstract] [Full Text] [Related]

  • 12. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.
    Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V.
    BMJ; 2012 Jun 13; 344():e3533. PubMed ID: 22695899
    [Abstract] [Full Text] [Related]

  • 13. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
    Andras A, Stansby G, Hansrani M.
    Cochrane Database Syst Rev; 2013 Jul 19; 2013(7):CD003285. PubMed ID: 23881650
    [Abstract] [Full Text] [Related]

  • 14. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
    Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Sleight P, Peto R, Collins R.
    JAMA; 2010 Jun 23; 303(24):2486-94. PubMed ID: 20571015
    [Abstract] [Full Text] [Related]

  • 15. Non-pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack.
    Mackay-Lyons M, Thornton M, Ruggles T, Che M.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD008656. PubMed ID: 23543566
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. B vitamins for stroke prevention.
    Hankey GJ.
    Stroke Vasc Neurol; 2018 Jun 28; 3(2):51-58. PubMed ID: 30022794
    [Abstract] [Full Text] [Related]

  • 18. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease.
    McKinley MC.
    Proc Nutr Soc; 2000 May 28; 59(2):221-37. PubMed ID: 10946791
    [Abstract] [Full Text] [Related]

  • 19. Homocysteine-lowering interventions are ineffective in preventing myocardial infarction.
    Brigo F, Storti M, Tezzon F, Nardone R.
    Int J Cardiol; 2013 Oct 12; 168(5):5055-6. PubMed ID: 23932865
    [No Abstract] [Full Text] [Related]

  • 20. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women.
    Gabriel SR, Carmona L, Roque M, Sánchez GL, Bonfill X.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD002229. PubMed ID: 15846631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.